Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient

Transplantation. 1996 Sep 27;62(6):869-72. doi: 10.1097/00007890-199609270-00030.

Abstract

This report describes a case of Epstein-Barr [correction of Epstein Barr] Virus related post-transplantation B lymphoproliferative disease of unusual Burkitt lymphoma (BL) type in which combined cytotoxic agents (PACE BOM) successfully produced complete and long-term tumor remission.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allopurinol / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Burkitt Lymphoma / drug therapy
  • Burkitt Lymphoma / etiology*
  • Burkitt Lymphoma / pathology
  • Cyclophosphamide / administration & dosage
  • Cyclosporine / adverse effects*
  • Cytarabine / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Heart Transplantation*
  • Herpesviridae Infections*
  • Herpesvirus 4, Human* / immunology
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Methotrexate / administration & dosage
  • Middle Aged
  • Postoperative Complications / etiology*
  • Prednisolone / administration & dosage
  • Remission Induction
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Cytotoxic / immunology
  • Tumor Virus Infections*
  • Vincristine / administration & dosage

Substances

  • Immunosuppressive Agents
  • Cytarabine
  • Bleomycin
  • Vincristine
  • Allopurinol
  • Etoposide
  • Doxorubicin
  • Cyclosporine
  • Cyclophosphamide
  • Prednisolone
  • Methotrexate

Supplementary concepts

  • PACE-BOM protocol